Literature DB >> 21717245

To cut is to cure: can we really apply Z11 in practice?

Monica Morrow, Armando E Giuliano.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21717245     DOI： 10.1245/s10434-011-1857-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  10 in total

1.  Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort.

Authors:  Fabian Riedel; Jörg Heil; Manuel Feißt; Mahdi Rezai; Mareike Moderow; Christof Sohn; Florian Schütz; Michael Golatta; André Hennigs
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

2.  Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis.

Authors:  Chihwan Cha; Eun Young Kim; Sung Yong Kim; Jai Min Ryu; Min Ho Park; Seokwon Lee; Young-Jin Suh; Nayeon Choi; Hanpyo Hong; Hyung Suk Kim; Min Sung Chung
Journal:  World J Surg Oncol       Date:  2022-06-13       Impact factor: 3.253

3.  American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.

Authors:  Abigail S Caudle; Kelly K Hunt; Susan L Tucker; Karen Hoffman; Sarah M Gainer; Anthony Lucci; Henry M Kuerer; Funda Meric-Bernstam; Ruchita Shah; Gildy V Babiera; Aysegul A Sahin; Elizabeth A Mittendorf
Journal:  Ann Surg Oncol       Date:  2012-07-31       Impact factor: 5.344

Review 4.  Landmark trials affecting the surgical management of invasive breast cancer.

Authors:  Dalliah M Black; Elizabeth A Mittendorf
Journal:  Surg Clin North Am       Date:  2013-01-29       Impact factor: 2.741

Review 5.  Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature.

Authors:  Claire M T P Francissen; Pim J M Dings; Thijs van Dalen; Luc J A Strobbe; Hanneke W M van Laarhoven; Johannes H W de Wilt
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

6.  The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study.

Authors:  Miao Liu; Shu Wang; Shude Cui; Xuening Duan; Zhimin Fan; Zhigang Yu
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

7.  Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.

Authors:  Ruoxi Hong; Zhen Dai; Wenjie Zhu; Binghe Xu
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

8.  Managing the Axilla in Early Breast Cancer. Impact of ACOSOG Z0011 Trial in Changing Practices in a Low Middlezzm321990Income Country

Authors:  Awais Amjad Malik; Namra Urooj; Romaisa Shamim; Mariam Salim; Razia Bano; Zulqurnain Chaudhry; Huma Majeed Khan; Amina Iqbal Khan
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

9.  What is the future of axillary surgery for breast cancer?

Authors:  M Ahmed; M Douek
Journal:  Ecancermedicalscience       Date:  2013-05-16

Review 10.  Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update.

Authors:  Sheikh Zahoor; Altaf Haji; Azhar Battoo; Mariya Qurieshi; Wahid Mir; Mudasir Shah
Journal:  J Breast Cancer       Date:  2017-09-22       Impact factor: 3.588
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.